Acquired factor V deficiency in a patient without evidence of a classical inhibitor.
作者信息
Sosa I R, Ellery P, Mast A, Neff A T, Gailani D
机构信息
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
出版信息
Haemophilia. 2014 Jan;20(1):e81-3. doi: 10.1111/hae.12280. Epub 2013 Oct 14.
Abstract
摘要
相似文献
1
Acquired factor V deficiency in a patient without evidence of a classical inhibitor.一名无典型抑制剂证据患者的获得性凝血因子V缺乏症
Haemophilia. 2014 Jan;20(1):e81-3. doi: 10.1111/hae.12280. Epub 2013 Oct 14.
2
Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.接触局部人凝血酶后获得性因子 V 抑制剂与耳鼻喉科手术相关。
J Thromb Haemost. 2015 Oct;13(10):1787-9. doi: 10.1111/jth.13114. Epub 2015 Sep 30.
3
Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency.在一名患有严重自身免疫性因子V缺乏症的九旬老人中，通过输注血小板成功管理经导管主动脉瓣植入术。
Ann Hematol. 2019 Aug;98(8):1991-1992. doi: 10.1007/s00277-019-03646-6. Epub 2019 Mar 4.
4
Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.一名患有尿路感染并出现血尿，随后发生多次出血且因子V抑制剂水平极低的患者获得性因子V缺乏症：病例报告及文献复习
Blood Coagul Fibrinolysis. 2017 Jun;28(4):334-341. doi: 10.1097/MBC.0000000000000581.
5
The potential value of thrombin generation assay in the diagnosis of FV inhibitors.凝血酶生成试验在FV抑制剂诊断中的潜在价值。
Int J Lab Hematol. 2019 Oct;41(5):e117-e120. doi: 10.1111/ijlh.13027. Epub 2019 Apr 6.
6
Development of cephradine-induced acquired factor V inhibitors: a case report.头孢拉定诱导获得性因子 V 抑制剂的发展：一例报告。
Ann Pharmacother. 2010 Oct;44(10):1673-6. doi: 10.1345/aph.1P324. Epub 2010 Aug 31.
7
[Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].
Rev Med Interne. 2011 May;32(5):e59-61. doi: 10.1016/j.revmed.2010.06.008. Epub 2010 Jul 17.
8
Transient Factor V deficiency associated with Factor V-immunoglobulin complexes but without evidence of a classical inhibitor.与因子V-免疫球蛋白复合物相关的短暂性因子V缺乏，但无经典抑制剂证据。
Thromb Res. 2016 Nov;147:10-12. doi: 10.1016/j.thromres.2016.09.013. Epub 2016 Sep 14.
9
A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
Ann Hematol. 2018 Oct;97(10):2009-2010. doi: 10.1007/s00277-018-3348-z. Epub 2018 May 1.
10
An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.一种与因子V功能缺陷、储存及与多聚体蛋白1结合相关的获得性因子V抑制剂。
J Thromb Haemost. 2008 Feb;6(2):395-7. doi: 10.1111/j.1538-7836.2008.02860.x. Epub 2007 Nov 28.
引用本文的文献
1
Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement.获得性因子 V 抑制剂伴妊娠相关改善，经免疫抑制治疗无效后延迟自发性缓解。
Pathol Oncol Res. 2023 Jun 2;29:1611250. doi: 10.3389/pore.2023.1611250. eCollection 2023.
2
A Case of Acquired Factor V Deficiency in Patient with Bleeding.一例出血患者获得性因子V缺乏症病例
TH Open. 2020 Apr 20;4(2):e77-e79. doi: 10.1055/s-0039-3402024. eCollection 2020 Apr.
3
Challenges in management of unusual acquired factor V deficiency: A case report.罕见获得性凝血因子V缺乏症的管理挑战：一例报告
Medicine (Baltimore). 2019 Apr;98(17):e15259. doi: 10.1097/MD.0000000000015259.
4
Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency.维持胚外组织表达可产生组织因子途径抑制物严重缺乏的小鼠。
Blood Adv. 2019 Feb 12;3(3):489-498. doi: 10.1182/bloodadvances.2018018853.
本文引用的文献
1
Tissue factor pathway inhibitor: structure-function.组织因子途径抑制剂：结构-功能。
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
2
Inherited and acquired factor V deficiency.遗传性和获得性因子V缺乏症。
Blood Coagul Fibrinolysis. 2011 Apr;22(3):160-6. doi: 10.1097/MBC.0b013e3283424883.
3
Acquired factor V inhibitors: a systematic review.获得性因子 V 抑制剂：系统评价。
J Thromb Thrombolysis. 2011 May;31(4):449-57. doi: 10.1007/s11239-010-0529-6.
4
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.严重先天性因子 V 缺乏症伴轻度出血症状患者中残留的血小板因子 V 可确保凝血酶生成。
Blood. 2010 Jan 28;115(4):879-86. doi: 10.1182/blood-2009-08-237719. Epub 2009 Oct 27.
5
Advances in understanding the bleeding diathesis in factor V deficiency.凝血因子V缺乏症出血素质认识的进展
Br J Haematol. 2009 Jun;146(1):17-26. doi: 10.1111/j.1365-2141.2009.07708.x. Epub 2009 Apr 27.
6
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.先天性因子V缺乏症患者血浆组织因子途径抑制物水平较低。
Blood. 2008 Nov 1;112(9):3615-23. doi: 10.1182/blood-2008-06-162453. Epub 2008 Aug 11.
7
Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.巨核细胞中内源性因子V的合成对血小板因子V池的贡献可忽略不计。
Haematologica. 2003 Oct;88(10):1150-6.
8
Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.危及生命的出血与原发性系统性淀粉样变性相关的获得性凝血因子V缺乏症。
Blood Coagul Fibrinolysis. 2002 Sep;13(6):555-9. doi: 10.1097/00001721-200209000-00011.
9
Factor-X deficiency in amyloidosis: a critical review.
Am J Hematol. 1981 Dec;11(4):443-50. doi: 10.1002/ajh.2830110414.
Zotero 插件